The use of the vaccine, branded Spikevax, will be the same in children from 12 to 17 years as in people aged 18 and above, the European Medicines Agency (EMA) said.
EU regulator endorses use of Moderna COVID-19 vaccine in teens
By REUTERS
03/19/2024 03:10 AM
By REUTERS
03/19/2024 02:42 AM
By REUTERS
03/19/2024 01:15 AM
By REUTERS
03/18/2024 11:37 PM
By REUTERS
03/18/2024 10:18 PM
By REUTERS
03/18/2024 08:40 PM
By REUTERS
03/18/2024 07:55 PM